Abstract:Lan Xia, 1, &ast Ping Zhang, 2, &ast Jing-Wen Niu, 2 Wei Ge, 2 Jun-Tao Chen, 2 Shuai Yang, 2 Ai-Xi Su, 2 Yi-Zhou Feng, 2 Fang Wang, 3 Gong Chen, 4 Gui-Hai Chen 2 1 Department of Neurology, The Second Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 2 Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University, Hefei (Chaohu), People's Republic of China; 3 Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, People's Republic of China; 4 Hefei Technology College, Hefei (Chaohu), People's Republic of China &astThese authors contributed equally to this work Correspondence: Gui-Hai Chen Department of Neurology (Sleep Disorders), The Affiliated Chaohu Hospital of Anhui Medical University, Hefei (Chaohu), People's Republic of China Tel/Fax +86-551-82321571 Email 163.com Gong Chen Hefei Technology College, Hefei (Chaohu), People's Republic of China Tel +86-551-82367072 Fax +86-551-82351650 Email Purpose: To examine whether associations exist between chronic insomnia disorder (CID) and overlooked inflammatory factors (Serum amyloid protein A [SAA]), tumor necrosis factor [TNF]-α, granulocyte-macrophage colony-stimulating factor [GM-CSF], and regulated on activation and normal T cell expressed and presumably secreted [RANTES]). Patients and Methods: A total of 65 CID patients and 39 sex- and age-matched good sleeper (GS) controls participated in this study. They completed a baseline survey to collect data on demographics, and were elevated sleep and mood by Pittsburgh Sleep Quality Index (PSQI), Athens Insomnia Scale (AIS), 17-item Hamilton Depression Rating Scale (HAMD-17) and 14-item Hamilton Anxiety Rating Scale (HAMA-14), respectively. The blood samples were collected and tested the serum levels of SAA, TNF-α, GM-CSF and RANTES. Results: The CID group had higher serum levels of SAA, TNF-α, and GM-CSF and a lower level of RANTES than the GS group. In the Spearman correlation analysis, SAA and GM-CSF positively correlated with the PSQI and AIS scores. After controlling for sex, HAMD-17 score, and HAMA-14 score, the partial correlation analysis showed that GM-CSF was positively correlated with PSQI score. Further stepwise linear regression analyses showed that GM-CSF was positively associated with the PSQI and AIS scores, while RANTES was negatively associated with them, and SAA was positively associated with just the AIS score. Conclusion: The serum levels of inflammatory mediators (SAA, TNF-α, and GM-CSF) were significantly elevated and the level of RANTES was significantly decreased in CID patients and, to some extent, the changes are related to the severity of insomnia. These findings may help us to improve interventions to prevent the biological consequences of CID by inhibiting inflammation, thereby promoting health. Keywords: chronic insomnia disorder, serum amyloid protein A; tumor necrosis factor (TNF)-α, granulocyte-macrophage colony-stimulating factor, regulated on activation and normal T cell expressed and presumably secreted In the general population, about a third of individuals have sleep complaints, and nearly 10% fulfill the diagnostic criteria for chronic insomnia disorder (CID). 1 CID has a strong impact on quality of life and is a risk factor for the development of other disorders, including psychological disease, 2 , 3 cardiovascular disease, 4 diabetes, 5 certain cancers, 6 obesity, 7 and functional decline. This has substantial public health implications. In recent years, sleep research has increasingly focused on the biological mechanisms underlying these associations between insomnia and somatic diseases, 8–10 with substantial attention on the effect of chronic sleep loss on inflammation. Compelling evidence has demonstrated that sleep disturbance (defined as difficulty initiating or maintaining sleep) and shorter sleep duration are associated with elevated inflammatory biomarkers, which may be linked to increased risk of chronic diseases. 11–13 A systematic review and meta-analysis of 72 studies (n > 50,000) examined associations between insomnia and the proinflammatory markers interleukin (IL)-6 and the acute-phase protein C-reactive protein (CRP).< -Abstract Truncated-

Elevations in interleukin‐8 levels in individuals with alcohol use disorder and clinical insomnia symptoms

An exploratory study of pro-inflammatory cytokines in individuals with alcohol use disorder: MCP-1 and IL-8 associated with alcohol consumption, sleep quality, anxiety, depression, and liver biomarkers

Chronic Insomnia Is Associated with Higher Circulating Interleukin-8 in Patients with Atherosclerotic Cerebral Small Vessel Disease

Relationships Between a Range of Inflammatory Biomarkers and Subjective Sleep Quality in Chronic Insomnia Patients: A Clinical Study

Insomnia symptoms predict systemic inflammation in women, but not in men with inflammatory bowel disease

Insomnia treatment effects on negative emotionality among veterans in treatment for alcohol use disorder

Gender Differences in the Relationship Between Alcohol Consumption and Insomnia in the Northern Chinese Population.

Disordered sleep, nocturnal cytokines, and immunity in alcoholics

Nss_a_239030 93..99

Sleep Features in Alcohol Use Disorder: A Systematic Review and Meta-Analysis of Polysomnographic Findings in Case-Control Studies

Treatment of insomnia associated with alcohol and opioid use: a narrative review

Aberrations in peripheral inflammatory cytokine levels in substance use disorders: a meta-analysis of 74 studies

Reductions in World Health Organization risk drinking level are associated with improvements in sleep problems among individuals with alcohol use disorder

Associations between insomnia symptoms and inflammatory cytokines in adolescents with first-episode and recurrent major depressive disorder

Do sleep and circadian characteristics predict alcohol use in adult drinkers?

Research on the correlation of immunity in patients with chronic insomnia

Sleep as an Important Target or Modifier in Alcohol Use Disorder Clinical Treatment: Example From a Recent Gabapentin Randomized Clinical Trial

Markers of intestinal barrier damage in patients with chronic insomnia disorder

Relationship between sleep and serum inflammatory factors in patients with major depressive disorder

The Relationship between Alcohol- and Sleep-related Traits: Results from Polygenic Risk Score Analyses and Mendelian Randomization Studies

Changes in insomnia and binge‐eating symptom severity before and after treatment of eating disorders in individuals with non‐low‐weight binge‐spectrum disorders